Anal cancers are predominantly preceded by screening-detectable high-grade squamous intraepithelial lesions (HSILs). Despite being relatively uncommon in the general population, possessing an incidence rate of 1.7 per 100,000 person-years, anal cancers disproportionately affects specific groups of individuals, particularly people with human immunodeficiency virus (HIV), solid organ transplant recipients and women with a history of vulvar cancer or precancer.

Laryngeal cancer is one of the most common types of head and neck cancers worldwide, with 5-year survival rates as high as 80%-90% for patients with early-stage tumors (i.e., stage I or II), and decrease sharply to 40% among those at advanced stage. Multimodal therapy combining surgery, radiotherapy and/or chemotherapy is often necessary for patients with advanced disease (i.e., stage III or IV). Certain patients such as the elderly may not be able to tolerate standard therapy well. However, these patients may need palliative treatment, which aims to improve their quality of life (QoL) and provide symptom relief. In this interview with Omnihealth Practice, Dr. Choy, Tim-Shing discussed the use of palliative radiotherapy among elderly patients with advanced laryngeal cancer and shared a clinical case todemonstrate its real-world applications.

Ovarian cancer remains the most deadly gynecologic malignancy, and its incidence has been steadily increasing over the past few decades. In Hong Kong, ovarian cancer is the 7th leading cause of female cancer deaths. The crude death rate was 5.5 per 100,000 female population. In 2017, a total of 218 women died from this cancer, accounting for 3.7% of all cancer deaths in females. In a recent interview, Dr. William Foo, Specialist in Clinical Oncology, shared his insights on the management of ovarian cancer in Hong Kong.